Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. Defence Therapeutics Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
Show more...
FAQ
Defence Therapeutics 今天的股價是多少?▼
DTC.CN 目前價格為 C$0.53 CAD,過去 24 小時下跌了 -3.64%。在圖表上更密切關注 Defence Therapeutics 股票的表現。
Defence Therapeutics 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Defence Therapeutics 的股票以代號 DTC.CN 進行交易。
Defence Therapeutics 的股價在上漲嗎?▼
DTC.CN 股票較上週上漲 +1.92%,本月下跌 -11.67%,過去一年 Defence Therapeutics 下跌 -44.79%。
Defence Therapeutics 上一季度的財報如何?▼
DTC.CN 上一季度的財報為每股 -0.05 CAD,預估為 不適用 CAD,帶來 不適用 的驚喜。下一季度的預估財報為每股 不適用 CAD。
Defence Therapeutics 去年的營收是多少?▼
Defence Therapeutics 去年的營收為 0CAD。
Defence Therapeutics 去年的淨利是多少?▼
DTC.CN 去年的淨收益為 -7.04MCAD。
Defence Therapeutics 位於哪個產業?▼
Defence Therapeutics從事於Healthcare產業。
Defence Therapeutics 何時完成拆股?▼
Defence Therapeutics 最近沒有進行任何拆股。
Defence Therapeutics 的總部在哪裡?▼
Defence Therapeutics 的總部位於 CA 的 Vancouver。